Lv7
4690 积分 2024-03-27 加入
Dual B-cell targeting in systemic lupus erythematosus: The role of combined and sequential therapy with rituximab and belimumab
1个月前
已完结
Panax notoginseng Saponins Prevents Atherosclerosis and Reverse Steroid-Resistance in Lupus Nephritis via Promoting the "M2-Polarization of Macrophages-PPARγ" Positive Regulation
1个月前
已完结
Caspase Recruitment Domain 6 ( CARD6) is the therapeutic target of dihydroartemisinin for lupus nephritis based on Proteolysis Targeting Chimera (PROTAC) technology
1个月前
已完结
Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?
1个月前
已完结
METTL3-targeted intervention on nuclear factors RORA/RORγt suppresses pathogenic T helper 17 cell differentiation and alleviates kidney damage in lupus nephritis
1个月前
已完结
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study
1个月前
已完结
Mesenchymal Stromal Cell Therapy Alleviates Lupus Nephritis Through Inhibiting Caspase‐4/5/11–Mediated Noncanonical Pyroptosis in Macrophages
1个月前
已完结
Efficacy and safety of dapagliflozin in inactive lupus nephritis: a randomized crossover trial
1个月前
已完结
Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis
1个月前
已完结
Lupus nephritis
1个月前
已完结
皖公网安备34019202002308
